Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Rx Must Address “Anger” Over Drug Prices, AARP’s Rother Says

Executive Summary

AARP remains convinced that Congress needs to address the high price of prescription drugs

You may also be interested in...

Reimportation In North America Is Inevitable, Roche Suggests; EU Is Model

A U.S./Canada pharmaceutical importation system may be inevitable, Roche Global Pharmaceutical Head William Burns suggested during an Oct. 16 investor conference call

AARP Supports Canadian Imports To Place “Downward Pressure” On Rx Costs

AARP is endorsing prescription drug reimportation from Canada as a measure to help control the cost of drugs

Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx

The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts